PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION

PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION was reported 6 times

PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chloride Channel Activator [EPC] 1 0.0001
1 Iron Chelator [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 2 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
4 Alkylating Drug [EPC] 2 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
6 Corticosteroid [EPC] 3 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
8 Atypical Antipsychotic [EPC] 1 0.0000